Confluent Surgical

Waltham, United States Founded: 1998 • Age: 28 yrs Acquired By Integra LifeSciences
Dural repair, surgical sealants, and adhesion barrier products are developed.
Annual revenue - Latest available
Total funding $55.0M 4 rounds
Employees - Tracked headcount
Investors 11 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Confluent Surgical

Confluent Surgical is a company based in Waltham (United States) founded in 1998 was acquired by Integra LifeSciences in October 2013. Confluent Surgical has raised $55 million across 4 funding rounds from investors including Integra LifeSciences, GE Capital and Ascension Ventures. Confluent Surgical operates in a competitive market with competitors including ClearFlow, Rejoni, Advanced Medical Solutions, Endius and Cordis, among others.

  • Headquarter Waltham, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $55 M (USD)

    in 4 rounds

  • Latest Funding Round
    $23 M (USD), Series D

    Mar 28, 2005

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Integra LifeSciences

    (Oct 28, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Confluent Surgical

Confluent Surgical has successfully raised a total of $55M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $23 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series D — $23.0M
  • First Round
  • Investors Count 10
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2005 Amount Series D - Confluent Surgical Valuation

investors

Jun, 2002 Amount Series C - Confluent Surgical Valuation EW Healthcare Partners
Nov, 2000 Amount Series B - Confluent Surgical Valuation TVM Capital

Investors in Confluent Surgical

Confluent Surgical has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Integra LifeSciences, GE Capital and Ascension Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Strategic investments in healthcare technologies and data innovations.
Founded Year Domain Location
Investments are made in early to mid-stage US companies.
Founded Year Domain Location
VC firm investing in expansion stage tech and life sciences companies in the US
Founded Year Domain Location

Investments & Acquisitions by Confluent Surgical

Investments

Financial Statements - Confluent Surgical

Confluent Surgical Comparisons

+
Add Comparison
Available on Premium

Competitors of Confluent Surgical

Confluent Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ClearFlow, Rejoni, Advanced Medical Solutions, Endius and Cordis, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Anti-clogging technologies for medical drainage catheters are developed.
domain founded_year HQ Location
Therapeutics for women's health conditions are developed using innovative hydrogels.
domain founded_year HQ Location
Wound care products and surgical dressings are developed.
domain founded_year HQ Location
Minimally invasive devices for spine surgery procedures are provided.
domain founded_year HQ Location
Cardiovascular and endovascular devices are developed and marketed by Cordis.

Latest news on Confluent Surgical

Frequently Asked Questions about Confluent Surgical

Confluent Surgical was founded in 1998.

Confluent Surgical is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Confluent Surgical is a funded company, having raised a total of $55M across 4 funding rounds to date. The company's 1st funding round was a Series B of $12M, raised on Jun 01, 1998.

Confluent Surgical was founded in 1998 in Waltham, United States, within the medical device sector. Products focused on dural repair, surgical sealants, and adhesion barriers are developed, including DuraSeal, DuraSeal ExactXact, VascuSeal, and SprayShield. Operations center on these specialized surgical solutions. An acquisition agreement for the product lines was reached between Integra LifeSciences Holdings Corporation and Covidien.

Confluent Surgical's top competitors include Rejoni, Cordis and ClearFlow.

Confluent Surgical has 11 investors. Key investors include Integra LifeSciences, GE Capital, Ascension Ventures, Cross Atlantic Capital Partners, and HLM Venture Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available